Tokyo, Sept. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058962) titled 'Study on the Effects of Teduglutide on the Gut Microbiota of Pediatric Patients with Short Bowel Syndrome' on Sept. 10.
Study Type:
Observational
Primary Sponsor:
Institute - University of Tsukuba
Condition:
Condition - Short Bowel Syndrome
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to elucidate the gut microbiota composition in pediatric short bowel syndrome (SBS) patients treated with teduglutide and to investigate the presence of treatment-specific microbial alterations through comparison with published datasets.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - 15
years-old
>=
Gender - Male and Female
Key inclusion criteria - Children with short bowel syndrome (SBS) aged 15 years or younger receiving teduglutide
Key exclusion criteria - Patients who have had an infectious or inflammatory disease within the past 3 months
Patients who have been receiving teduglutide for less than 1 month since initiation
Patients deemed ineligible by the principal investigator for any other reason
Target Size - 5
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 08 Month 26 Day
Date of IRB - 2025 Year 08 Month 26 Day
Anticipated trial start date - 2025 Year 08 Month 26 Day
Last follow-up date - 2026 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067428
Disclaimer: Curated by HT Syndication.
